marginally significantP = .061
However, there was a marginally significant reduction ( P = .061) in the fecal butyrate concentration in the rifaximin group. 3.4.
However, there was a marginally significant reduction ( P = .061) in the fecal butyrate concentration in the rifaximin group. 3.4.
In this comparison, the P -value was .0506, representing borderline significance, which might be attributed to an insufficient number of studies.